Improved quality of life with rituximab plus methotrexate in patients with active rheumatoid arthritis who experienced inadequate response to one or more anti-TNFα therapies

被引:0
|
作者
Keystone, E. C.
Burmester, G. R.
Furie, R. A.
Loveless, J. E.
Emery, P.
Isaacs, J.
Jubb, R.
Dawes, P.
Cravets, M. W.
Magrini, F.
机构
[1] Univ Toronto, Toronto, ON, Canada
[2] Univ Med Berlin, Charite, Berlin, Germany
[3] N Shore LIJ Hlth Syst, Lake Success, NY USA
[4] Intermt Orthopaed, Boise, ID USA
[5] Gen Infirm, Leeds LS1 3EX, W Yorkshire, England
[6] Univ Newcastle Upon Tyne, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[7] Univ Hosp, Solihull, W Midlands, England
[8] Univ Hosp N Staffordshire, Stoke On Trent, Staffs, England
[9] Biogen Idec Inc, San Diego, CA USA
[10] Roche Prod Ltd, Welwyn Garden City AL7 3AY, Herts, England
来源
RHEUMATOLOGY | 2006年 / 45卷
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:I46 / I47
页数:2
相关论文
共 50 条
  • [1] Improved quality of life with rituximab plus methotrexate in patients with active rheumatoid arthritis who experienced inadequate response to one or more anti-TNF-α therapies
    Keystone, EC
    Burmester, GR
    Furie, R
    Loveless, JE
    Emery, P
    Cravets, MW
    Magrini, F
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S141 - S142
  • [2] Predictors of response to rituximab in patients with active rheumatoid arthritis and inadequate response to anti-TNF agents or traditional DMARDs
    Narvaez, J.
    Diaz-Torne, C.
    Ruiz, J. M.
    Hernandez, M. V.
    Torrente-Segarra, V.
    Ros, S.
    Rodriguez de la Serna, A.
    Diaz-Lopez, C.
    Sanmarti, R.
    Nolla, J. M.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (06) : 991 - 997
  • [3] Efficacy and safety of rituximab in active RA patients who experienced inadequate responses to one or more TNF inhibitors
    Cohen, S. B.
    Greenwald, M.
    Dougados, M.
    Emery, P.
    Furie, R.
    Shaw, T.
    Totoritis, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 108 - 109
  • [4] Abatacept provides clinical benefits in rheumatoid arthritis (RA) patients who previously demonstrated a lack of response or no response to one or more anti-TNF therapies
    Keystone, E.
    Aranda, R.
    Becker, J-C
    Covucci, A.
    Genovese, M. C.
    [J]. JOURNAL OF RHEUMATOLOGY, 2007, 34 (07) : 1630 - 1630
  • [5] Optimizing outcomes in patients with rheumatoid arthritis and an inadequate response to anti-TNF treatment
    Emery, Paul
    [J]. RHEUMATOLOGY, 2012, 51 : V22 - V30
  • [6] Clinical Utility and Cost Savings in Predicting Inadequate Response to Anti-TNF Therapies in Rheumatoid Arthritis
    Bergman, Martin J.
    Kivitz, Alan J.
    Pappas, Dimitrios A.
    Kremer, Joel M.
    Zhang, Lixia
    Jeter, Anna
    Withers, Johanna B.
    [J]. RHEUMATOLOGY AND THERAPY, 2020, 7 (04) : 775 - 792
  • [7] Clinical Utility and Cost Savings in Predicting Inadequate Response to Anti-TNF Therapies in Rheumatoid Arthritis
    Martin J. Bergman
    Alan J. Kivitz
    Dimitrios A. Pappas
    Joel M. Kremer
    Lixia Zhang
    Anna Jeter
    Johanna B. Withers
    [J]. Rheumatology and Therapy, 2020, 7 : 775 - 792
  • [8] Abatacept provides clinical benefits in rheumatoid arthritis (RA) patients who previously demonstrated a lack of response or no response to one or more anti-TNF therapies.
    Keystone, E.
    Aranda, R.
    Becker, J-C
    Covucci, A.
    Genovese, M. C.
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S406 - S406
  • [9] EFFICACY OF SARILUMAB PLUS CSDMARDS IN RHEUMATOID ARTHRITIS PATIENTS WHO HAD AN INADEQUATE RESPONSE TO ONE OR MORE THAN ONE PRIOR TNF INHIBITOR
    Genovese, M.
    Pinheiro, G.
    Mangan, E.
    Lin, Y.
    Van Hoogstraten, H.
    Fleischmann, R.
    [J]. INTERNAL MEDICINE JOURNAL, 2017, 47 : 29 - 29
  • [10] Efficacy of Sarilumab Plus csDMARDs in Rheumatoid Arthritis Patients who had an Inadequate Response to One or More than One Prior TNF Inhibitor
    Genovese, Mark
    Pinheiro, Geraldo
    Mangan, Erin
    Lin, Yong
    van Adelsberg, Janet
    van Hoogstraten, Hubert
    Kimura, Toshio
    Fleischmann, Roy
    Fiore, Stefano
    [J]. JOURNAL OF RHEUMATOLOGY, 2017, 44 (06) : 896 - 896